Autoimmune disease and epigenome regulation

Area of Science:

• Immunology
• Epigenetics
• Genomics

Background:

• Epigenetic modifications, including DNA methylation and histone modification, regulate gene expression.
• Genome-Wide Association Studies (GWAS) suggest that genetic variants associated with immune diseases are located in immune enhancers.
• Understanding epigenetic regulation of enhancers is key to understanding immune disease pathogenesis.

Purpose of the Study:

• To investigate the role of epigenetic modifications in immune diseases.
• To analyze genome-wide DNA methylation patterns in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
• To explore the potential of new technologies for analyzing epigenetic marks in limited clinical samples.

Main Methods:

• Epigenome-wide analysis of DNA methylation.
• Analysis of differential DNA methylation in gene pathways related to SLE and RA.
• Utilizing recent technical advances to capture open chromatin from small patient samples.

Main Results:

• Differential DNA methylation was identified in gene pathways associated with SLE and RA.
• Technical advancements now permit the analysis of histone modifications (open chromatin) in small patient samples, overcoming previous limitations.

Conclusions:

• Epigenetic modifications integrate environmental factors and genetic variants, influencing immune disease progression.
• Detailed epigenetic analysis, combined with genetic and environmental data, is essential for understanding human immunological diseases.
• Future research should focus on integrating multi-omics data for a comprehensive understanding of immune disease mechanisms.